FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multip... (anding of disease mechanisms and industr...)

FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma

Date:6/20/2008

anding of disease mechanisms and industrialized drug discovery platform, Millennium is developing an exciting pipeline of innovative product candidates. The Millennium website is http://www.millennium.com.

About Takeda

Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website, http://www.takeda.com.

Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com

Contacts:

Karen Gobler (Millennium) Seizo Masuda (Takeda)

(617) 444-1392 (011-81) 3-3278-2037

karen.gobler@mpi.com masuda_seizo@takeda.co.jp

Jennifer Snyder (Millennium)

(617) 444-1439

jennifer.snyder@mpi.com

(1) VELCADE as Initial Standard Therapy in multiple myeloma: Assessment

with melphalan and prednisone

SOURCE Millennium Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Japan Approves CyberKnife System for Extracranial Use
2. FDA approves NeuRx diaphragm pacing system for use in spinal cord- injured patients
3. FDA Approves Cymbalta(R) for the Management of Fibromyalgia
4. ClearWay Minnesota(SM) Board Approves $1.4 Million in New Grants to Reduce Tobaccos Harm
5. FDA Approves AstraZenecas Seroquel(R) for Maintenance Treatment in Bipolar Disorder
6. FDA Approves NOVO NORDISKs NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
7. FDA Approves Taclonex Scalp(R) - Once Daily Therapy for Treatment of Moderate to Severe Scalp Psoriasis
8. FDA Approves Health Claim for Brown Rice
9. FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents
10. FDA approves HeartMate II mechanical heart pump for heart-failure patients
11. FDA Approves Advair(R) 250/50 for Reduction of Exacerbations in Patients With COPD

Post Your Comments:

(Date:6/19/2013)... After investing efforts for months in ... formally announced the launch of database integration for the ... latest entry in the list of extraordinary vehicles lined ... redesigned 2012 Nissan NV is all ready to get ... , Provided with two high power capable engines, the ...

(Date:6/19/2013)... Audibel Hearing Center is pleased ... patients, the A2 with Multiflex Tinnitus Technology. Tinnitus ... in the ears. Although bothersome, tinnitus usually isn’t ... , Using their patent-pending Multiflex Tinnitus Technology, the ... sound stimulus that resonates through the patient’s ear. ...

(Date:6/19/2013)... June 19, 2013 According to Vanessa ... abusers called “psychonauts” are creating new designer drugs featuring ... research of published documents and patented formulas. She reported ... & Now on June 4. , “Some of ... They’re never tested on humans. Maybe some of them ...

(Date:6/19/2013)... The Report "Data Center Security Market ... DLP, UTM, IAM, SIEM, DR, ILM); Physical Security ... Advancements, Forecasts & Analysis (2013-2018)", defines and segments ... sub-segments with in-depth analysis and forecasting of revenues. ... market with insights into trends, opportunities, and challenges. ...

(Date:6/19/2013)... Tewkesbury, UK (PRWEB) June 19, 2013 ... solutions, is sponsoring today's event, at which it will ... issues, as well as giving further insight into its ... gathering for IT & business professionals specialising in IDM ... wide range of markets including the public sector, banking, ...

Breaking Medicine News(10 mins):Health News:Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV 2 Health News:Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology 2 Health News:Dangerous Designer Drugs Dodge Legal System 2 Health News:Dangerous Designer Drugs Dodge Legal System 3 Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 2 Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 3 Health News:Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets 4

[0] Rim Fitments Expert, SizeItUp Comes Up With Database Integrations For The 2012 Nissan NV [0] Audibel Hearing Center Introduces A2 with Multiflex Tinnitus Technology [0] Dangerous Designer Drugs Dodge Legal System [0] Data Center Security Market is Poised to Grow at A CAGR of 16.3% & to Reach $13.77 Billion By 2018 - New Report by MarketsandMarkets [0] Tools4ever exhibits at Identity Management 2013

... a study by a researcher from University of California, ... are found not in the similarity of the genome ... them. ,Researcher had described genetic differences between the ... that is also expressed in brain cells associated with ...

... be available in pharmacies as over the counter drug ... women to avoid unnecessary pregnancy. The decision was announced// ... the governments decision the minister said, "The step has ... such situations as unprotected sexual exposure, contraceptive accident or ...

... from the Steno Diabetes Center, Denmark has found ... taking //antihypertensive drugs, reduced the chances of developing ... protein in urine of these patients. ... prone to kidney diseases. Supplementation of Spironolactone has ...

... of AIDS and 35 people have died of it in the ... at more than 100 and more than 2,000 full-blown AIDS cases. ... very low awareness in Jharkand. ,Jharkand plans to open ... of HIV spread. This new attempt to open the condom booths ...

... losing their eyesight later in life than non-smokers, says a ... UK with age-related macular degeneration (AMD). Of these, an ... smoking.// ,AMD usually develops after a person reaches ... of the eye. A report by AMD Alliance UK, based ...

... The lancet says that a combination of newer ... procedures.// ,Hypertension is the most important preventable ... the benefits of anti-hypertensive drugs for prevention of ... no individual trial using standard diuretic or Beta-blocker ...

Cached Medicine News:Health News:Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug 2

Human Diseases May Have Clue In Human-Chimp Genome Difference Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients Condom vending machine to be started in Jharkand Smokers Face The Risk Of Becoming Blind In Later Life New Drugs For High Blood Pressure Better Than Old Ones

(Date:6/18/2013)... Pharmaceuticals, Inc. (NASDAQ: ISIS ), the leader in ... corporate update in conjunction with its 2013 Annual Meeting of ... p.m. Pacific Time in Carlsbad, CA. ... 2:00 p.m. – 2:10 p.m. Annual Meeting of Stockholders (only ... p.m. – 3:15 p.m. Corporate Presentation – Stanley T. ...

(Date:6/17/2013)... , June 17, 2013 Vanda ... presented additional data today at ENDO 2013, the ... that tasimelteon can entrain (synchronize) both melatonin and ... to reset the master body clock and address ... Disorder (Non-24). The SET (Safety and Efficacy of ...

(Date:6/17/2013)... 17, 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... has filed a preliminary prospectus supplement to its effective shelf ... similar filing with securities regulatory authorities in each of the ... a public offering of its common shares to raise gross ... Company will also grant to the underwriters of the Offering ...

Breaking Medicine Technology:Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House 2 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 2 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 3 Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder 4 Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2 Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3 Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4

[0] Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House [0] Vanda Presents Data From Phase III Studies that Demonstrate Tasimelteon Restores Daily Cortisol Rhythm In Blind Patients With Non-24-Hour Disorder [0] Valeant Pharmaceuticals Announces Public Offering Of Common Shares

... Reportlinker.com announces that a new market research report ... Global Markets for Catheters http://www.reportlinker.com/p0801348/Global-Markets-for-Catheters.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... STUDY GOALS AND OBJECTIVES ... in conducting this study was to determine the present ...

... Experts from PAREXEL International Corporation (NASDAQ: ... will advise biopharmaceutical companies on how to successfully navigate ... Drug Information Association (DIA) 24th Annual EuroMeeting. The meeting ... Copenhagen, Denmark. Consultants from PAREXEL will be ...

Global Markets for Catheters PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting

Blunt Weitlaner Retractor....

Weitlaner Beckmann retractor, sharp prongs, SS....

Baby Weitlaner retractor, blunt, 4"....

Scoville sharp curette, 10, straight, scoop size 4 x 10 mm....

Medicine Products:

Blunt Weitlaner Retractor Weitlaner Beckmann Retractor Baby Weitlaner Retractor Scoville Sharp Curette